MedPath

Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients

Completed
Conditions
Acute Kidney Injury
Interventions
Other: Collection of clinical and biological data during renal replacement therapy sessions
Registration Number
NCT04444765
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Acute kidney injury (AKI) affects up to 30% of critically ill patients and is associated with increased rates of mortality. Up to 60% of patients with AKI will ultimately require renal replacement therapy (RRT). Intermittent hemodialysis (IHD) is one of the main methods of RRT worldwide. In IHD-bicar, dialysate is composed by electrolytes, including calcium, and bicarbonate. To avoid calcium carbonate precipitation, dialysate has to be supplemented with acids (citric acid, chloride acid or acetic acid). However, IHD-bicar may be associated with hemodynamic instability or respiratory intolerance, mainly related to the CO2 release in the circulation during IHD (HCO3- \<--\> CO2 + H2O). Some recent studies showed that acetate free biofiltration (AFB-K), a technique that does not require dialysate acidification, could be associated with better hemodynamic stability and to a lower amount of CO2 delivered to the patients. AFB-K may thus improve the hemodynamic and respiratory tolerance of intermittent RRT in critically ill patients.

Detailed Description

In this prospective observational study, investigators aim to characterize the hemodynamic and respiratory tolerances of HDI-bicar and AFB-K in critically ill patients requiring RRT.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients ≥ 18 years old
  • Invasive monitoring of blood pressure
  • Non opposition to the research
  • Admission to the intensive care unit
  • Need of intermittent hemodialysis
Exclusion Criteria
  • Sodium bicarbonate infusion
  • Pregnancy or breastfeeding
  • Juridical protection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with bicarbonate-based intermittent dialysisCollection of clinical and biological data during renal replacement therapy sessionsDialysate is composed by electrolytes, including calcium, and bicarbonate. To avoid calcium carbonate precipitation, dialysate has to be supplemented with acids (citric acid, chloride acid or acetic acid).
Patients with acetate free biofiltration dialysisCollection of clinical and biological data during renal replacement therapy sessionsAcetate free biofiltration (AFB-K)is a technique that does not require dialysate acidification
Primary Outcome Measures
NameTimeMethod
Occurence of hemodynamic eventFrom admission to discharge, up to 4 hours

The occurrence of at least one of the following events will be considered a hemodynamic event :

* Hypotension (decrease of systolic or mean blood pressures ≥ 15 and ≥ 10% respectively)

* Tachycardia (increase of heart beating ≥ 20%)

* Cardiac arrythmia (junctional tachycardia, atrial fibrillation, flutter, ventricular tachycardia or fibrillation)

* Decrease of the cardiac output ≥ 15% (only in patients with invasive cardiac output monitoring)

* Starting (or increase dosing) of norepinephrine ≥ 0.1 µg/kg/min

Secondary Outcome Measures
NameTimeMethod
Change in the "strong ion difference"baseline, 4 hours

Evaluation of the "strong ion difference" by blood ionogram

Change in plasma pH1 hour after the beginning of dialysis session, up to 4 hours

Evaluation of plasma pH by blood ionogram

Change in maximal PaCO21 hour after the beginning of dialysis , up to 4 hours

Evaluation of PaCO2 by arterial blood gas test

Maximum difference of tcPCO2 and etCO2From admission to discharge, up to 4 hours

Evaluation of TcPCO2 and etCO2 by trans-cutaneous measurement

Trial Locations

Locations (1)

Hôpital Rangueil

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath